The National Cancer Institute (NCI) has awarded the Siteman Cancer Center and Washington University School of Medicine in St. Louis a prestigious Specialized Program of Research Excellence (SPORE) grant in endometrial cancer.
Endometrial cancer, which forms in the tissue lining the uterus, is the most common gynecologic cancer. Last year, about 42,000 women were diagnosed with the disease and almost 8,000 women with endometrial cancer died.
The majority of women diagnosed with endometrial cancer are 45 years or older.
The prognosis of surviving endometrial cancer is good when the disease is detected and treated early. However, if the cancer has spread from the uterus, the chances to treat it successfully are small.
The goal of SPORE grants is to implement a strong collaboration between basic scientists and clinicians. The three-year, $1.7 million SPORE grant in endometrial cancer brings together School of Medicine experts in genomics, diagnostics and developmental therapeutics to tackle research projects that can be translated quickly into improved detection and treatment of this type of cancer. This research involves both cancer patients and populations at risk for cancer.
No comments:
Post a Comment